Apotex Inc.

Industry

  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
    • Drug Delivery
    • OTC, Consumer
  • Biotechnology
    • Drug Discovery Technologies

Other Names/Subsidiaries

  • Apobiologix
  • ApoPharma
  • Apotex Australia
  • Arrow Pharmaceuticals
  • Arrow Remedies Private Limited
  • Arrotex Australia Group
  • Aveva Drug Delivery Systems
  • Searchlight Pharma
  • ApoPharma
See more in Biomedtracker

Latest on Apotex Inc.

Generics Bulletin

Apotex Follows Biocon With Canadian Biosimilar Aflibercept Launch

 
• By Dean Rudge

Health Canada has approved Apotex’s Aflivu (aflibercept) biosimilar to Bayer/Regeneron’s Eylea 2mg, marking the second announced approval for a biosimilar to the VEGF inhibitor in the space of a week.

Generics Bulletin

After Dasatinib Apotex Debuts US Tasigna Competition

 
• By Dean Rudge

With 180 days of market exclusivity, Apotex has launched the first US generic version of Novartis’ Tasigna (nilotinib) blockbuster treatment for chronic phase and accelerated phase Philadelphia chromo

Scrip

Asia Deal Watch: Lilly Partners With Rznomics On Hearing Loss

 
• By Joseph Haas, Xu Hu, Anju Ghangurde, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On

Scrip

Deal Watch: Amgen, CytomX Pull Back On Part Of T-Cell Engager Collaboration

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CytomX, Amgen Decision Follows January